Pimecrolimusdosage

Apply a thin layer of Pimecrolimus Cream, 1% to the affected skin twice daily. The patient should stop using Pimecrolimus Cream, 1% when signs and symptoms (e.g., itch, rash and redness) resolve and should be instructed on what actions to take if symptoms recur. If signs and symptoms persist beyond 6 weeks, patients should be re-examined by their healthcare provider to confirm the diagnosis of atopic dermatitis. Continuous long-term use of Pimecrolimus Cream, 1% should be avoided, and application should be limited to areas of involvement with atopic dermatitis. The safety of Pimecrolimus Cream, 1% under occlusion, which may promote systemic exposure, has not been evaluated. Avoid use of Pimecrolimus Cream, 1% with occlusive dressings.

Apply a thin layer of Pimecrolimus Cream, 1% to the affected skin twice daily.

If signs and symptoms persist beyond 6 weeks, patients should be re-examined.

Continuous long-term use of Pimecrolimus Cream, 1% should be avoided.

Avoid use with occlusive dressings.